文献
J-GLOBAL ID:201902275537011344
整理番号:19A1298719
日本における非典型溶血性-尿毒症症候群小児患者に対するエクリズマブの安全性および有効性:市販後調査の中間分析
Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance
著者 (15件):
Ito Shuichi
(Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan)
,
Hidaka Yoshihiko
(Clinical Division of Pediatrics, Shinshu University Hospital, Matsumoto, Nagano, Japan)
,
Inoue Norimitsu
(Department of Tumor Immunology, Osaka International Cancer Institute, Osaka, Japan)
,
Kaname Shinya
(Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan)
,
Kato Hideki
(Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan)
,
Matsumoto Masanori
(Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Nara, Japan)
,
Miyakawa Yoshitaka
(Department of General Internal Medicine, Thrombosis and Hemostasis Center, Saitama Medical University Hospital, Iruma-gun, Saitama, Japan)
,
Mizuno Masashi
(Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan)
,
Okada Hirokazu
(Saitama Medical University, Iruma-gun, Saitama, Japan)
,
Shimono Akihiko
(Alexion Pharma GK, Tokyo, Japan)
,
Matsuda Takahisa
(Alexion Pharma GK, Tokyo, Japan)
,
Maruyama Shoichi
(Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan)
,
Fujimura Yoshihiro
(Japanese Red Cross Kinki Block Blood Center, Ibaraki, Osaka, Japan)
,
Nangaku Masaomi
(Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan)
,
Kagami Shoji
(Department of Pediatrics, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan)
資料名:
Clinical and Experimental Nephrology (Web)
(Clinical and Experimental Nephrology (Web))
巻:
23
号:
1
ページ:
112-121
発行年:
2019年
JST資料番号:
U1582A
ISSN:
1342-1751
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)